Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Про Lite Strategy

Засновано2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Спільнота
Twitter
Website
Мітки
Publicly listed company
Crypto Stocks

Тренд зміни гарячого індексу

Немає записів

Члени команди

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

Деталі збору коштів

Post-IPO(2025-07-21)
Сума₴4,49B
Рас. Ціна--